Rachel Green Recent research into cannabidiol (CBD), a non-psychoactive cannabinoid, shows promising signs for the treatment of several psychiatric conditions, according to a critical review of existing studies. The review focused on clinical studies published before July 27, 2023, scrutinizing the effects of CBD on conditions such as schizophrenia, substance use disorders (SUDs), anxiety, post-traumatic stress disorder … Read more
A pivotal review has brought cannabidiol (CBD) into the spotlight, reaffirming its potential as a game-changer in the treatment of epilepsy, especially in its drug-resistant forms. Centered on Epidiolex, a refined pharmaceutical version of CBD and the first cannabis-derived medication approved by regulators, the study provides profound insights into CBD’s therapeutic benefits. The research delves … Read more
A recent Forbes Health survey conducted by OnePoll has highlighted a significant trend among Gen Z users of cannabidiol (CBD), with 22% reporting they use CBD to alleviate menstrual cramps. This finding is part of a broader examination into the expanding use of CBD products across various age groups in the United States, reflecting the … Read more
In a groundbreaking study, researchers have unearthed nuanced findings about the effects of cannabidiol (CBD) on brain cells, revealing that while low doses of the compound can protect against certain types of cell damage, higher doses may actually be harmful. This new research highlights the complex nature of CBD’s interaction with the brain’s neuronal cells … Read more
In a significant development at a recent public hearing with Commission III of the Indonesian House of Representatives in Jakarta, Professor Musri Musman, Chairperson of the Sativa Foundation Trustee and a respected researcher from Syiah Kuala University, presented compelling evidence supporting the therapeutic potential of CBD (cannabidiol) oil for treating cerebral palsy. During his presentation, … Read more